The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Poluektov M.G.

Sechenov First Moscow State Medical University (Sechenov University)

The use of psychotropic medications for chronic insomnia in clinical practice

Authors:

Poluektov M.G.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(4‑2): 61‑66

DOI: 10.17116/jnevro202112104261

Read: 16453 times

Download PDF (RU)
Contact the author
Table of contents

THE USE OF PSYCHOTROPIC MEDICATIONS FOR CHRONIC INSOMNIA IN CLINICAL PRACTICE
THE USE OF PSYCHOTROPIC MEDICATIONS FOR CHRONIC INSOMNIA IN CLINICAL PRACTICE

To cite this article:

Poluektov MG. The use of psychotropic medications for chronic insomnia in clinical practice. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(4‑2):61‑66. (In Russ.)
https://doi.org/10.17116/jnevro202112104261

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Stress and sleep: Neurobiological aspe­cts and modern options of inso­mnia therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):14-21
Factors of depression acco­rding to acti­graphy in the fall season. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):27-32
Consensus of the Russian Society of Sleep Medi­cine on the real-world application of cognitive-behavioral therapy of inso­mnia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):38-45
Inso­mnia in children. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):46-51
Vali­dation of ballistocardiography data for predicting the sleep effi­ciency in healthy indi­viduals and patients with inso­mnia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):60-66
Carbonyl stress in meno­pausal women with inso­mnia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):192-197
Treatment of acute postoperative pain and prevention of chro­nic postoperative pain syndrome. Piro­gov Russian Journal of Surgery. 2024;(12):81-86
Subjective sleep quality evaluation in patients with neuromyelitis optica spectrum diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):57-61
Sleep deprivation and the deve­lopment of oxidative stress in animal models. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):124-129
The state of mental health of migrant workers and citi­zens of the Russian Fede­ration: A comparative analysis as illu­strated by the Moscow region. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):95-101
Abstract:

Chronic insomnia is a common sleep disorder. In its treatment, both non-drug and drug approaches are used. The therapeutic concept is based on a three-component model of sleep regulation. Psychotropic drugs of various pharmacological groups are used for the treatment of chronic insomnia. The peculiarities of the effect of these drugs in various clinical situations are discussed.

Keywords:

sleep
insomnia
hypnotics
pharmacotherapy
cognitive-behavior therapy of insomnia

Authors:

Poluektov M.G.

Sechenov First Moscow State Medical University (Sechenov University)

Received:

06.04.2021

Accepted:

06.04.2021

Close metadata

References:

  1. Somnologija i medicina sna. Nacional’noe rukovodstvo pamjati A.M. Vejna i Ja.I. Levina (2-e izd., dop. i pererab.). Pod red. Poluektova M.G.. M.: Medkongress; 2020. (In Russ.).
  2. Riemann D, Baglioni C, Bassetti C, Bjorvatn B, Dolenc Groselj L, Ellis JG, Espie CA, Garcia-Borreguero D, Gjerstad M, Gonçalves M, Hertenstein E, Jansson-Fröjmark M, Jennum PJ, Leger D, Nissen C, Parrino L, Paunio T, Pevernagie D, Verbraecken J, Weeß HG, Wichniak A, Zavalko I, Arnardottir ES, Deleanu OC, Strazisar B, Zoetmulder M, Spiegelhalder K. European guideline for the diagnosis and treatment of insomnia. J Sleep Res. 2017;26(6):675-700.  https://doi.org/10.1111/jsr.12594
  3. Kripke DF. Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit. F1000Res. 2016;5:918.  https://doi.org/10.12688/f1000research.8729.3
  4. Sweetman A, Putland S, Lack L, McEvoy RD, Adams R, Grunstein R, Stocks N, Kaambwa B, Van Ryswyk E, Gordon C, Vakulin A, Lovato N. The effect of cognitive behavioural therapy for insomnia on sedative-hypnotic use: A narrative review. Sleep Med Rev. 2021;56:101404. https://doi.org/10.1016/j.smrv.2020.101404
  5. Saper CB, Chou TC, Scammell TE. The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci. 2001;24(12):726-731.  https://doi.org/10.1016/s0166-2236(00)02002-6
  6. Stone BM, Turner C, Mills SL, Paty I, Patat A, Darwish M, Danjou P. Noise-induced sleep maintenance insomnia: hypnotic and residual effects of zaleplon. Br J Clin Pharmacol. 2002;53(2):196-202.  https://doi.org/10.1046/j.-5251.2001.01520.x
  7. Arroll B, Fernando A 3rd, Falloon K, Goodyear-Smith F, Samaranayake C, Warman G. Prevalence of causes of insomnia in primary care: a cross-sectional study. Br J Gen Pract. 2012;62(595):e99-103.  https://doi.org/10.3399/bjgp12X625157
  8. Nierenberg AA, Keefe BR, Leslie VC, Alpert JE, Pava JA, Worthington JJ 3rd, Rosenbaum JF, Fava M. Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry. 1999;60(4):221-225.  https://doi.org/10.4088/jcp.v60n0403
  9. Sakurai H, Uchida H, Kato M, Suzuki T, Baba H, Watanabe K, Inada K, Kikuchi T, Katsuki A, Kishida I, Sugawara Kikuchi Y, Yasui-Furukori N; Medical Education Panel of the Japanese Society of Clinical Neuropsychopharmacology. Pharmacological management of depression: Japanese expert consensus. J Affect Disord. 2020;266:626-632.  https://doi.org/10.1016/j.jad.2020.01.149
  10. Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2017;13(2):307-349.  https://doi.org/10.5664/jcsm.6470
  11. Wilson S, Anderson K, Baldwin D, Dijk DJ, Espie A, Espie C, Gringras P, Krystal A, Nutt D, Selsick H, Sharpley A. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update. J Psychopharmacol. 2019;33(8):923-947.  https://doi.org/10.1177/0269881119855343
  12. Scantlebury A, Mcdaid C, Dawson V, Elphick H, Fairhurst C, Hewitt C, Parker A, Spiers G, Thomas M, Wright K, Beresford B. Non-pharmacological interventions for non-respiratory sleep disturbance in children with neurodisabilities: a systematic review. Dev Med Child Neurol. 2018;60(11):1076-1092. https://doi.org/10.1111/dmcn.13972
  13. Haimov I, Laudon M, Zisapel N, Souroujon M, Nof D, Shlitner A, Herer P, Tzischinsky O, Lavie P. Sleep disorders and melatonin rhythms in elderly people. BMJ. 1994;309(6948):167.  https://doi.org/10.1136/bmj.309.6948.167
  14. Wade AG, Crawford G, Ford I, McConnachie A, Nir T, Laudon M, Zisapel N. Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response. Curr Med Res Opin. 2011;27(1):87-98.  https://doi.org/10.1185/03007995.2010.537317
  15. Parrino L, Smerieri A, Giglia F, Milioli G, De Paolis F, Terzano MG. Polysomnographic study of intermittent zolpidem treatment in primary sleep maintenance insomnia. Clin Neuropharmacol. 2008;31(1):40-50.  https://doi.org/10.1097/wnf.0b013e3180674e0e
  16. Morin CM, Beaulieu-Bonneau S, Ivers H, Vallières A, Guay B, Savard J, Mérette C. Speed and trajectory of changes of insomnia symptoms during acute treatment with cognitive-behavioral therapy, singly and combined with medication. Sleep Med. 2014;15(6):701-707.  https://doi.org/10.1016/j.sleep.2014.02.004
  17. Beaulieu-Bonneau S, Ivers H, Guay B, Morin CM. Long-Term Maintenance of Therapeutic Gains Associated With Cognitive-Behavioral Therapy for Insomnia Delivered Alone or Combined With Zolpidem. Sleep. 2017;40(3):zsx002. https://doi.org/10.1093/sleep/zsx002
  18. Morin CM, Bélanger L, LeBlanc M, Ivers H, Savard J, Espie CA, Mérette C, Baillargeon L, Grégoire JP. The natural history of insomnia: a population-based 3-year longitudinal study. Arch Intern Med. 2009;169(5):447-453.  https://doi.org/10.1001/archinternmed.2008.610
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.